Los Angeles, CA, United States of America

Mohammad Pashmforoush


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Diabetes Treatment by Mohammad Pashmforoush

Introduction

Mohammad Pashmforoush is an accomplished inventor based in Los Angeles, CA. He has made significant contributions to the field of diabetes treatment, particularly focusing on methods to combat insulin resistance and type II diabetes. His innovative approach has the potential to improve the lives of many individuals affected by these conditions.

Latest Patents

Pashmforoush holds a patent for "Diabetes treatment methods and drug targets therefor." This patent outlines methods for treating insulin resistance or type II diabetes by disrupting CAP in macrophages. This disruption can alter the inflammatory response associated with impaired insulin action, ultimately leading to improved insulin action in target tissues. The invention involves administering a CAP antagonist to patients in an amount sufficient to enhance insulin action.

Career Highlights

Currently, Mohammad Pashmforoush is affiliated with the University of California, where he continues to advance research in diabetes treatment. His work is characterized by a commitment to developing effective therapeutic strategies for managing insulin resistance.

Collaborations

Pashmforoush collaborates with notable colleagues, including Kenneth R Chien and Lisa Lesniewski. Their combined expertise contributes to the innovative research being conducted in the field of diabetes treatment.

Conclusion

Mohammad Pashmforoush's contributions to diabetes treatment through his innovative patent demonstrate his dedication to improving health outcomes for individuals with insulin resistance and type II diabetes. His work at the University of California and collaborations with esteemed colleagues further highlight the importance of innovation in medical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…